Article
Detection of activating mutations in liquid biopsy of Egyptian breast cancer patients using targeted next-generation sequencing: a pilot study.
Journal of the Egyptian National Cancer Institute - 17 Apr 2021
Kassem Neemat, Kassem Hebatallah, Kassem Loay, Hassan Mohamed
Abstract excerpt
BACKGROUND: Breast cancer (BC) is the 2nd most prevalent malignancy worldwide and is the most prevalent cancer among Egyptian women. The number of newly described cancer-associated genes has grown exponentially since the emergence of next-generation sequencing (NGS) technology. We aim to identify activating mutations in liquid biopsy of Egyptian breast cancer patients using targeted NGS technology. We also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.